Department of Cellular Signaling, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan.
Cell Signal. 2013 Mar;25(3):589-97. doi: 10.1016/j.cellsig.2012.11.021. Epub 2012 Nov 29.
Gα(h) (or transglutaminase-2 (TG2)) is an atypical guanine nucleotide binding-protein that associates with G protein-coupled receptors. TG2 also exerts transglutaminase activity that catalyzes posttranslational protein cross-linking with the formation of ε-(γ-glutamyl) lysine or (γ-glutamyl) polyamine bonds. Here, the role of Gα(h)/TG2 in signal transduction in glial cells was examined in detail. In 1321N1 human astrocytoma cells that lack Gα(h)/TG2, overexpression of Gα(h)/TG2 caused an enhancement of cAMP accumulation stimulated with the β-adrenergic receptor agonist, isoproterenol, or the adenylylcyclase activator, forskolin. This cAMP-enhancement was reversed by the TG2 inhibitor, ERW1069. In rat C6 glioma cells that express endogenous Gα(h)/TG2, cAMP accumulation induced by isoproterenol or forskolin was significantly inhibited by overexpression of Gα(h)/TG2-C277V, a dominant-negative mutant that lacks transglutaminase activity, but was not inhibited by the Gα(h)/TG2-S171E mutant that cannot bind GTP/GDP. These results suggest Gα(h)/TG2 potentiates adenylylcyclase activity by its transglutaminase activity and not by its G-protein activity. Gα(h)/TG2 also increased the activities of the cAMP response element and interleukin-6 promoter, accompanied by an of cAMP in both glioma cells. Since adenylylcyclase 8 plays a major role in cAMP production, we focused on post-translational modification of adenylylcyclase 8 by Gα(h)/TG2. Adenylylcyclase 8 is expressed in both 1321N1 and C6 cells; however, Gα(h)/TG2 affected neither adenylylcyclase 8 expression levels, glycosylation, nor dimerization status. In contrast, pentylamine, a substrate of Gα(h)/TG2, was incorporated into adenylylcyclase 8 in a transglutaminase activity-dependent manner. Taking these results together, Gα(h)/TG2 promotes cAMP production accompanied by a modification of adenylylcyclase 8 in glioma cells.
Gα(h)(或转谷氨酰胺酶-2 (TG2))是一种非典型的鸟嘌呤核苷酸结合蛋白,与 G 蛋白偶联受体结合。TG2 还具有转谷氨酰胺酶活性,可催化翻译后蛋白质交联,形成 ε-(γ-谷氨酰基)赖氨酸或 (γ-谷氨酰基)多胺键。在这里,详细研究了 Gα(h)/TG2 在神经胶质细胞信号转导中的作用。在缺乏 Gα(h)/TG2 的 1321N1 人星形细胞瘤细胞中,过表达 Gα(h)/TG2 可增强β-肾上腺素能受体激动剂异丙肾上腺素或腺苷酸环化酶激活剂 forskolin 刺激的 cAMP 积累。这种 cAMP 增强作用可被 TG2 抑制剂 ERW1069 逆转。在表达内源性 Gα(h)/TG2 的大鼠 C6 神经胶质瘤细胞中,异丙肾上腺素或 forskolin 诱导的 cAMP 积累显著被过表达缺乏转谷氨酰胺酶活性的显性失活突变体 Gα(h)/TG2-C277V 抑制,但不受不能结合 GTP/GDP 的 Gα(h)/TG2-S171E 突变体抑制。这些结果表明 Gα(h)/TG2 通过其转谷氨酰胺酶活性而不是其 G 蛋白活性增强腺苷酸环化酶活性。Gα(h)/TG2 还增加了 cAMP 反应元件和白细胞介素-6 启动子的活性,并伴有 cAMP 在两种神经胶质瘤细胞中的增加。由于腺苷酸环化酶 8 在 cAMP 产生中起主要作用,因此我们专注于 Gα(h)/TG2 对腺苷酸环化酶 8 的翻译后修饰。腺苷酸环化酶 8 在 1321N1 和 C6 细胞中均有表达;然而,Gα(h)/TG2 既不影响腺苷酸环化酶 8 的表达水平、糖基化,也不影响二聚体状态。相比之下,戊胺是 Gα(h)/TG2 的底物,以转谷氨酰胺酶活性依赖的方式掺入腺苷酸环化酶 8 中。综上所述,Gα(h)/TG2 在神经胶质瘤细胞中促进 cAMP 产生并伴有腺苷酸环化酶 8 的修饰。